1 – 10 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation
(
- Contribution to journal › Article
- 2018
-
Mark
Bruton’s tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma
(
- Contribution to journal › Article
-
Mark
XK-related protein 5 (XKR5) is a novel negative regulator of KIT/D816V-mediated transformation
(
- Contribution to journal › Article
- 2017
-
Mark
Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
(
- Contribution to journal › Article
-
Mark
ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling
(
- Contribution to journal › Article
-
Mark
KITD816V induces SRC-mediated tyrosine phosphorylation of MITF and altered transcription program in melanoma
(
- Contribution to journal › Article
- 2016
-
Mark
Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling
(
- Contribution to journal › Article
-
Mark
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
(
- Contribution to journal › Article
- 2015
-
Mark
BEX1 acts as a tumor suppressor in acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner.
(
- Contribution to journal › Article